Literature DB >> 8549008

Epidemiology of diabetes mellitus in Canada.

M H Tan1, D R MacLean.   

Abstract

We present data on 5 aspects of the epidemiology of diabetes mellitus in Canada: (a) the incidence of insulin-dependent diabetes mellitus in those under 15 years of age. The 2 Canadian centres that participated in the Diabetes Epidemiology Research International study had different incidence rates in IDDM:25.5/100,000 in Prince Edward Island (PEI) and 9.2/100,000 in Montreal. The reasons for this difference are not yet established. Studies on incidence of IDDM over a decade in PEI showed an apparent epidemic of the disease; (b) the prevalence of self-reported diabetes mellitus in Canadian adults. The overall prevalence of self-reported diabetes in Canadian adults (18-74 y) was 5.1% in the Canadian Heart Health Survey. There were no significant regional differences in prevalence of diabetes across Canada. The prevalence rates increased with age; (c) mortality data in people with diabetes mellitus. In PEI, 321 persons with diabetes died between January 1, 1982 and December 31, 1984, accounting for about 2% of all deaths. Diabetes was listed as the underlying cause in 16.8% of the deaths, as a contributing cause of death in 41.7%, and not mentioned at all in 41.1% of the deaths. Irrespective of whether diabetes was mentioned or not, myocardial infarction and cerebral vascular disease were the 2 major causes of deaths in these 321 persons with diabetes; (d) the prevalence of cardiovascular risk factors in Canadian adults with diabetes mellitus. In the Canadian Heart Health Survey, the prevalence rates of obesity, hypertension, sedentary lifestyle, and hypercholesterolemia were higher in the diabetic group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8549008

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  12 in total

1.  Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

Authors:  H C Gerstein; S Meltzer
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

Review 2.  Microalbuminuria in diabetes mellitus.

Authors:  Sheldon W Tobe; Philip Alan McFarlane; David Malcolm Naimark
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

Review 3.  Taking on diabetes. Family doctors on the front lines of the battle against diabetes.

Authors:  S B Harris; A C Macaulay
Journal:  Can Fam Physician       Date:  1998-11       Impact factor: 3.275

4.  Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada.

Authors:  Douglas Coyle; Andrew J Palmer; Robert Tam
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 5.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

6.  The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach.

Authors:  G Dranitsaris; C J Longo; L D Grossman
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

7.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

8.  The cost of major comorbidity in people with diabetes mellitus.

Authors:  Scot H Simpson; Paula Corabian; Philip Jacobs; Jeffrey A Johnson
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

9.  The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates.

Authors:  Fatma Al-Maskari; Mohammed El-Sadig; John N Norman
Journal:  Cardiovasc Diabetol       Date:  2007-09-19       Impact factor: 9.951

10.  Diabetes in Canadian Women.

Authors:  Catherine Kelly; Gillian L Booth
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.